(Q33646488)

28 July 2017

title

Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice (English)

1 reference

28 July 2017

10

Cheng-Feng Qin

0 references

Yong-Qiang Deng

4

object named as

Yong-Qiang Deng

1 reference

28 July 2017

Yue-Xiang Li

1

1 reference

28 July 2017

Hui Zhao

2

1 reference

28 July 2017

Rui-Yuan Cao

3

1 reference

28 July 2017

Jian-Feng Han

5

1 reference

28 July 2017

Shun-Ya Zhu

6

1 reference

28 July 2017

Jie Ma

7

1 reference

28 July 2017

Long Liu

8

1 reference

28 July 2017

E-De Qin

9

1 reference

28 July 2017

language of work or name

1 reference

6 May 2014

1 reference

28 July 2017

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

page(s)

79

1 reference

https://scigraph.springernature.com/pub.10.1186/1743-422x-11-79

28 July 2017

exact match

0 references

cites work

DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Progress on the research and development of inactivated EV71 whole-virus vaccines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Identification and characterization of a cross-neutralization epitope of Enterovirus 71.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Epitope discovery and their use in peptide based vaccines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Enterovirus 71 Infection of Monocytes with Antibody-Dependent Enhancement

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Producing infectious enterovirus type 71 in a rapid strategy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

EV71: an emerging infectious disease vaccine target in the Far East?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

28 July 2018

Enterovirus 71 in Taiwan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Genetic evolution of enterovirus 71: epidemiological and pathological implications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

More than one reason to rethink the use of peptides in vaccine design

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

DNA vaccine constructs against enterovirus 71 elicit immune response in mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Epitope identification and vaccine design for cancer immunotherapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Epidemiology of hand, foot, and mouth disease and genotype characterization of Enterovirus 71 in Jiangsu, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Combined peptides of human enterovirus 71 protect against virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Optimizing vaccine design for cellular processing, MHC binding and TCR recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-11-79

WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030048

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines

30 October 2018

1 reference

12 December 2020

Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71

1 reference

12 December 2020

Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides

1 reference

12 December 2020

Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides

1 reference

12 December 2020

A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses

1 reference

12 December 2020

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

DOI

10.1186/1743-422X-11-79

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1743-422x-11-79

9 September 2019

1 reference

28 July 2017

1 reference